Aimo Kannt und Frankfurt - Info zur Person

(1 - 22 von 24

)

Proxidrugs: a new tool to fight pathogens? - Labiotech.euwww.labiotech.eu › News and Trends

www.labiotech.eu

· Aimo Kannt, head of drug discovery and preclinical research at Fraunhofer ITMP in Frankfurt, is currently researching the new class of drugs ...

Proxidrugs in the fight against pathogenic proteinsMedical Xpress

medicalxpress.com

— Aimo Kannt, head of drug discovery and preclinical research at Fraunhofer ITMP in Frankfurt, is currently researching a new class of drugs with ...

Loop | Aimo KanntLoop | Research Network

loop.frontiersin.org

Aimo Kannt. Habilitation. Manager. Primary. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP. Frankfurt, Germany. Director.

Proxidrugs in the fight against pathogenic proteinsidw-online.de › -DDbLAA

idw-online.de

· Aimo Kannt, Head of Drug Discovery and Preclinical Research at Fraunhofer ITMP in Frankfurt, is currently researching a new class of drugs with ...

patentbuddy: Aimo KANNT

SANOFI, Frankfurt am Main, DE

PLOS ONE: Systemic Treatment with Erythropoietin Protects the...

journals.plos.org

Aimo Kannt. Affiliation Sanofi Diabetes Research and Translational Medicine, Frankfurt, Germany. Matthias Kolibabka. Affiliation 5th Medical ...

Incretin combination therapy for the treatment of non‐alcoholic ...Wiley

dom-pubs.onlinelibrary.wiley.com

von A Kannt · · Zitiert von: 27 — Aimo Kannt, Sanofi Research and Development, D Frankfurt, Germany Peer Review The peer review history for this article is available at ...

Novel Biomarkers for Change in Renal Function in People ...diabetesjournals.org

diabetesjournals.org

von HC Gerstein · · Zitiert von: 7 — Aimo Kannt. 3Sanofi Aventis Deutschland GmbH Research and Development, Frankfurt, Germany. Search for other works by this author on:.

Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic...

www.scienceopen.com

Frankfurt am Main, Germany. Contributors. Aimo Kannt: + , + , . Journal.

Goethe-Universität — BioMed FIRST VeranstaltungenGoethe-Universität Frankfurt

www.uni-frankfurt.de

09. Mai. Drug Discovery: From target validation to clinical development with PD Dr. Aimo Kannt Mai. Leitung Herstellung & Senior Projektmanagement

Forschungsbereich Präklinische Forschung - Fraunhofer ITMP

www.itmp.fraunhofer.de

PD Dr. Aimo Kannt. Forschungsbereichsleiter Drug Discovery. Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP Industriepark Höchst, G Frankfurt am Main. Telefon +

Organisation - Fraunhofer ITMP

www.itmp.fraunhofer.de

PD Dr. Aimo Kannt. Forschungsbereichsleiter Drug Discovery und Präklinische Forschung. Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP Industriepark Höchst, G Frankfurt am Main. Telefon +

Goethe University Frankfurtwww.goethe-university-frankfurt.de › ...

www.goethe-university-frankfurt.de

Workshops. Nov 15. Drug Discovery Lecture: From Target Validation to Lead Optimization With PD Dr. Aimo Kannt. Oct Projektmanagement

Englischtheranova.eu

www.theranova.eu

PD Dr. Aimo Kannt. Head of Research Division Drug Discovery. Fraunhofer Institute for Translational Medicine and Pharmacology Frankfurt am Main, ...

GRADE BioMed FIRST - previous workshops & lecturesGoethe University Frankfurt

www.goethe-university-frankfurt.de

GRADE BioMed FIRST - previous workshops & lectures ; Nov 15. Drug Discovery Lecture: From Target Validation to Lead Optimization With PD Dr. Aimo Kannt ; Oct. 13-

Enable initiative

enable-frankfurt.de

PD Dr. Aimo Kannt. Fraunhofer Institute for Translational Medicine and Pharmacology Industriepark Hoechst, G Frankfurt am Main.

Group Leader (m/f/d) In-vivo PharmacologyEuropean Society of Laboratory Animal Veterinarians

www.eslav.org

Name: Dr. Aimo Kannt. Website: https://jobs.fraunhofer.de/job/Frankfurt-am-Main-Group-Leader-%28mfd%29-In-vivo-Pharmacology

Aimo - Patent applicationswww.patentsencyclopedia.com › inventor › aimo-7

www.patentsencyclopedia.com

Aimo Kannt, Frankfurt Am Main DE ; , CYCLOHEXYLAMIN ISOQUINOLONE DERIVATIVES - The invention relates to 6-cyclohexylamine-substituted isoquinolone ...

Fraunhofer Research News featuring the ...proxidrugs

www.proxidrugs.de

— PROXIDRUGS project leader Aimo Kannt, Head of Drug Discovery and Preclinical Research at Fraunhofer ITMP in Frankfurt, presented PROXIDRUGS ...

VolkswagenStiftung funds MACROVIRemthera

www.emthera.de

— Eugen Proschak from University Frankfurt, Philip Gribbon from Fraunhofer Institute ITMP in Hamburg and EMTHERA researcher Aimo Kannt are ...

ISOQUINOLINE DERIVATIVES - Patent application

www.patentsencyclopedia.com

... Kurt Ritter (Frankfurt, DE) Matthias Loehn (Kelkheim, DE) Yuri Ivashchenko (Hattersheim, DE) Peter Monecke (Darmstadt, DE) Matthias Dreyer (Frankfurt, DE) Aimo Kannt

Alle Infos zum Namen "Aimo Kannt"

Verwandte Suchanfragen zu Aimo Kannt

Dieter Kadereit
Maarten Ruitenberg
Ernst Bamberg

Katja Kroll
Kerstin Sicka
Thorsten Sadowski

Anja Pfenninger
Markus Kohlmann
Hartmut Michel

Person "Kannt" (1)
Vorname "Aimo" (73)
Name "Kannt" (20)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Aimo Kannt und Frankfurt Person-Info